Detalles de la búsqueda
1.
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
Cancer
; 130(6): 876-885, 2024 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985359
2.
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood
; 140(5): 504-515, 2022 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35512184
3.
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
Br J Haematol
; 200(1): 35-44, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36068929
4.
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Lancet Oncol
; 23(3): 406-415, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35074072
5.
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma.
Haematologica
; 106(10): 2667-2672, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732355
6.
A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.
Oncologist
; 25(11): 963-973, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852137
7.
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma.
Haematologica
; 105(7): 1907-1913, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601688
8.
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.
Biol Blood Marrow Transplant
; 25(7): 1340-1346, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30763728
9.
Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial.
Br J Haematol
; 185(5): 874-882, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30919940
10.
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Br J Haematol
; 185(4): 670-678, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820940
11.
Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.
Ophthalmic Plast Reconstr Surg
; 35(3): 243-246, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30124609
12.
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma.
Br J Haematol
; 180(4): 545-549, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29271057
13.
Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma.
Blood
; 137(8): 1124-1129, 2021 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32932518
14.
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
Br J Haematol
; 177(2): 263-270, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28340281
15.
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Br J Haematol
; 176(5): 750-758, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27983760
16.
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma.
Oncologist
; 22(5): 549-553, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28408615
17.
Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma.
Ophthalmic Plast Reconstr Surg
; 33(5): 355-360, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27636243
18.
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
Cancer
; 122(20): 3145-3151, 2016 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27351173
19.
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
Br J Haematol
; 172(1): 80-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26648336
20.
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum ß2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
Br J Haematol
; 175(2): 290-299, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27448187